Change Bio
Change Bio speeds commercialization of novel proteins by turning AI-designed sequences into testable samples and scalable production batches. It uses precision fermentation and a replicable, modular bioprocess to produce recombinant proteins for food, cosmetics, and materials, enabling gram‑scale prototyping and scale-up. The company is a B2B protein production platform that removes the need for bespoke processes for each new sequence. Core technologies include AI-driven protein design compatibility, precision fermentation, and modular bioprocess engineering. Change Bio addresses the gap between protein discovery and commercial adoption by reducing time, cost, and development risk for protein producers and formulators.
Change Bio
Change Bio speeds commercialization of novel proteins by turning AI-designed sequences into testable samples and scalable production batches. It uses precision fermentation and a replicable, modular bioprocess to produce recombinant proteins for food, cosmetics, and materials, enabling gram‑scale prototyping and scale-up. The company is a B2B protein production platform that removes the need for bespoke processes for each new sequence. Core technologies include AI-driven protein design compatibility, precision fermentation, and modular bioprocess engineering. Change Bio addresses the gap between protein discovery and commercial adoption by reducing time, cost, and development risk for protein producers and formulators.
TL;DR
What they do: AI-powered precision fermentation platform to turn designed protein sequences into testable samples and scalable production batches for food, cosmetics, and materials
Founded: 2023
Headquarters: London, England (Imperial College area / registered addresses in UK)
Founders: Dr. Noah Sprent; Zoe Woods
Funding signal: Multiple rounds including grants; latest disclosed round a grant announced 2025-05-29
Company Overview
Problem Domain
Translating AI-designed protein sequences into testable samples and scalable manufacturing for commercial formulators and producers.
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent disclosed round listed as a grant
Investor Signal
“Backed by a mix of grants and early-stage investors including BlueYard Capital, CPT Capital, EIT Food, MassChallenge, and Undaunted The Greenhouse Accelerator”